Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.
Cloud Expo on Google News

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
SYS-CON.TV
Top Links You Must Click On


Natalie Douglas, CEO of Idis, Joins Global Genes | RARE Project Board of Directors

ALISO VIEJO, California and PRINCETON, New Jersey, Feb. 12, 2013 /PRNewswire/ -- Global Genes | RARE Project and Idis are pleased to announce the addition of Natalie Douglas, CEO of Idis, to the Global Genes | RARE Project Board of Directors.  

Throughout her career and now as CEO of Idis, Douglas has pursued the cause for providing access to medicines for patients with unmet medical needs.   Her experience in the pharmaceutical industry introduced her to the therapeutic challenges for physicians in managing the unmet medical needs of patients including those with cancer and AIDS.

As an organization, Idis reflects the deep commitment and compassion embodied by Douglas for patients in the rare disease community.   In 2012 alone, Idis helped more than 720,000 patients, including many with rare diseases, gain access to critical therapies.  The results-driven mindset of the organization has helped patients gain access even in the most challenging situations.

Recognizing the complex nature of addressing unmet medical needs, Douglas is a passionate advocate for creating more meaningful, productive connections between industry, regulatory authorities, and the patient advocacy community to identify and remove barriers to access. 

"We are honored to have Natalie join our Board of Directors; her passion and commitment to rare disease and its community is more than evident in all she does both personally and professionally.  She will bring tremendous value and insights to the organization as it works to create a larger impact globally," stated Nicole Boice, Founder/President Global Genes | RARE Project.

"Addressing the unmet medical needs in the rare disease community is especially challenging," noted Douglas.  "The Global Genes | RARE Project has created a much needed voice for these patients and their families.  I am delighted to join the board of an organization that has made such an impact for an underserved population and look forward to contributing to their important mission." 

The addition of Ms. Douglas to the Board of Directors will be the first of many announcements this year from Global Genes | RARE Project, as the organization works to secure additional board members that bring important expertise to this growing organization.

"Our organization is entering an important period of growth, expectations have increased, and Global Genes | RARE Project wants to ensure that it continues to deliver increased value to those whom we serve - the rare disease patient advocacy community," stated Boice.   

About Global Genes | RARE Project
Global Genes | RARE Project is a leading global rare and genetic disease patient advocacy organization.  Global Genes | RARE Project works to build and unify a global rare and genetic disease community and positively impact patients in their lifetime by offering programs designed to educate, empower, and support patients, advocates, foundations, and other rare disease focused organizations. www.globalgenes.org 

About Idis
Idis has 25 years experience of partnering with pharmaceutical and biotechnology companies to create regulatory-compliant, ethical access to medicines for healthcare professionals and their patients with unmet medical needs. Since 1987, Idis has developed and managed access to thousands of medicines from every therapeutic category, impacting the lives of hundreds of thousands of patients in countries around the world.  Idis leverages decades of experience, regulatory insight, and a thorough understanding of local and global requirements to create access to medicines at every stage of a product's lifecycle from pre-approval to market exit, and in times of unexpected production shortages.  The company's international headquarters are located in Weybridge, United Kingdom, and North American headquarters are located in Princeton, NJ. For more information, visit www.idispharma.com.

Contacts:  
Global Genes | RARE Project
Carrie Ostrea
Phone: +1-949-248-7273
Email: carrieo@rareproject.org

Idis
Christine Quern
Feinstein Kean Healthcare
Phone: +1-617-761-6791
Email: Christine.quern@fkhealth.com

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Enterprise Open Source Magazine Latest Stories . . .
The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to wait for long development cycles that produce software that is ob...
The recent trends like cloud computing, social, mobile and Internet of Things are forcing enterprises to modernize in order to compete in the competitive globalized markets. However, enterprises are approaching newer technologies with a more silo-ed way, gaining only sub optimal benefi...
WaveMaker on Tuesday announced WaveMaker Enterprise, licensed software that enables organizations to run their own end-to-end application platform as a service (aPaaS) for building and running custom apps. WaveMaker Enterprise is a commercially available rapid API app development and d...
The impact of DevOps in the cloud era is potentially profound. DevOps helps businesses deliver new features continuously, reduce cycle time and achieve sustained innovation by applying agile and lean principles to assist all stakeholders in an organization that develop, operate, or ben...
The industry is heated with debates on whether adopting private or public cloud is the smartest, best, cheapest, you name it choice. But this debate is missing the mark. Businesses shouldn’t be discussing public vs. private, but rather how can they make the two work together to their g...
After the transaction closes, Eucalyptus Chief Executive Officer (CEO) Marten Mickos, a respected leader in the cloud industry and a longtime advocate of open source, will join HP as senior vice president and general manager of the Cloud business, reporting to Meg Whitman, chairman, pr...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021




SYS-CON Featured Whitepapers
ADS BY GOOGLE